Cite
Bustinduy AL, Friedman JF, Kjetland EF, et al. Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis. PLoS Negl Trop Dis. 2016;10(9):e0004946doi: 10.1371/journal.pntd.0004946.
Bustinduy, A. L., Friedman, J. F., Kjetland, E. F., Ezeamama, A. E., Kabatereine, N. B., Stothard, J. R., & King, C. H. (2016). Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis. PLoS neglected tropical diseases, 10(9), e0004946. https://doi.org/10.1371/journal.pntd.0004946
Bustinduy, Amaya L, et al. "Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis." PLoS neglected tropical diseases vol. 10,9 (2016): e0004946. doi: https://doi.org/10.1371/journal.pntd.0004946
Bustinduy AL, Friedman JF, Kjetland EF, Ezeamama AE, Kabatereine NB, Stothard JR, King CH. Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis. PLoS Negl Trop Dis. 2016 Sep 22;10(9):e0004946. doi: 10.1371/journal.pntd.0004946. eCollection 2016 Sep. PMID: 27658198; PMCID: PMC5033572.
Copy
Download .nbib